18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.


PURPOSE To prospectively evaluate the effect of adding whole-body (18)F-2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) to conventional screening for distant metastases in patients with locally advanced breast cancer (LABC). PATIENTS AND METHODS All women with LABC referred for participation in the LABC Spinoza trial were considered… (More)


  • Presentations referencing similar topics